| Rachel Elisabeth Bridwell, MD | |
|
9040 Jackson Ave, Tacoma, WA 98431-4504 | |
| (253) 968-2252 | |
| Not Available |
| Full Name | Rachel Elisabeth Bridwell |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Location | 9040 Jackson Ave, Tacoma, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457854754 | NPI | - | NPPES |
| Entity Name | Western Washington Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801352505 PECOS PAC ID: 0749514735 Enrollment ID: O20190625002379 |
News Archive
For some, COVID-19 can result in severe pneumonia or even death, while others remain purely asymptomatic. A diagnostic tool could help physicians predict if a patient with COVID-19 will worsen.
Choice of arthrodesis for patients with rheumatoid arthritis or spondyloarthritis hindfoot disease should be guided by the extent of damage present, research indicates.
Global engineering and healthcare technologies company, Renishaw, is attending the second annual International 3D Printing in Medicine Conference in Mainz, Germany on May 19th-20th. Renishaw will demonstrate the opportunities that additive manufacturing (AM) creates in craniomaxillofacial surgery, by exhibiting its bespoke implants and providing demonstrations of its new implant design software, Additive-manufacture for Design-led Efficient Patient Treatment (ADEPT).
GlycoVaxyn AG, a leader in the development of innovative vaccines, announced today that the Phase I study of its Shigella dysenteriae bioconjugate vaccine has been completed and met the primary and secondary endpoints: demonstration of safety and immunogenicity.
› Verified 8 days ago
| Entity Name | Sound Physicians Emergency Medicine Of Washington Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629532064 PECOS PAC ID: 7315279007 Enrollment ID: O20191030000855 |
News Archive
For some, COVID-19 can result in severe pneumonia or even death, while others remain purely asymptomatic. A diagnostic tool could help physicians predict if a patient with COVID-19 will worsen.
Choice of arthrodesis for patients with rheumatoid arthritis or spondyloarthritis hindfoot disease should be guided by the extent of damage present, research indicates.
Global engineering and healthcare technologies company, Renishaw, is attending the second annual International 3D Printing in Medicine Conference in Mainz, Germany on May 19th-20th. Renishaw will demonstrate the opportunities that additive manufacturing (AM) creates in craniomaxillofacial surgery, by exhibiting its bespoke implants and providing demonstrations of its new implant design software, Additive-manufacture for Design-led Efficient Patient Treatment (ADEPT).
GlycoVaxyn AG, a leader in the development of innovative vaccines, announced today that the Phase I study of its Shigella dysenteriae bioconjugate vaccine has been completed and met the primary and secondary endpoints: demonstration of safety and immunogenicity.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachel Elisabeth Bridwell, MD 13268 Sleepy Hollow Ln, King George, VA 22485-4959 Ph: () - | Rachel Elisabeth Bridwell, MD 9040 Jackson Ave, Tacoma, WA 98431-4504 Ph: (253) 968-2252 |
News Archive
For some, COVID-19 can result in severe pneumonia or even death, while others remain purely asymptomatic. A diagnostic tool could help physicians predict if a patient with COVID-19 will worsen.
Choice of arthrodesis for patients with rheumatoid arthritis or spondyloarthritis hindfoot disease should be guided by the extent of damage present, research indicates.
Global engineering and healthcare technologies company, Renishaw, is attending the second annual International 3D Printing in Medicine Conference in Mainz, Germany on May 19th-20th. Renishaw will demonstrate the opportunities that additive manufacturing (AM) creates in craniomaxillofacial surgery, by exhibiting its bespoke implants and providing demonstrations of its new implant design software, Additive-manufacture for Design-led Efficient Patient Treatment (ADEPT).
GlycoVaxyn AG, a leader in the development of innovative vaccines, announced today that the Phase I study of its Shigella dysenteriae bioconjugate vaccine has been completed and met the primary and secondary endpoints: demonstration of safety and immunogenicity.
› Verified 8 days ago
Molly Cunard, General Practice Medicare: Medicare Enrolled Practice Location: 9040 Jackson Ave, Tacoma, WA 98431 Phone: 253-968-0117 | |
Courtney Lavin, General Practice Medicare: Medicare Enrolled Practice Location: 9040 Jackson Ave, Tacoma, WA 98431 Phone: 253-968-1790 | |
Dr. Glenn J. Kietzer, MD General Practice Medicare: Medicare Enrolled Practice Location: 15005 Pacific Ave, Spanaway General Medical, Tacoma, WA 98444 Phone: 253-537-3724 Fax: 253-537-6425 | |
Desislava Zlatanova Hite, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-8327 | |
Dr. Hannah Ghong-ju Ahn, MD General Practice Medicare: Medicare Enrolled Practice Location: 9040 Jackson Ave, Tacoma, WA 98431 Phone: 253-968-5604 Fax: 253-968-3140 | |
Marcus M Voss, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 9040 Jackson Ave, Tacoma, WA 98431 Phone: 253-968-1250 | |
Dr. Gregory Michael Johnston, M.D. General Practice Medicare: Medicare Enrolled Practice Location: Madigan Army Medical Center, Department Of Emergency Medicine, Tacoma, WA 98431 Phone: 253-968-1390 |